Gansu Province: 2111 products of 753 enterprises won the bid

On July 2, the centralized procurement network of drugs and medical consumables of Gansu Province released the notification on the bid winning results and related matters of centralized procurement of drugs in public hospitals of Gansu Province in 2017-2018 According to the notice, 4205 product specifications of 977 enterprises participated in the bidding application, 3639 product specifications of 945 enterprises met the bidding requirements and entered the bidding process, 3383 product specifications of 905 enterprises were successfully quoted, and 3381 product specifications of 903 enterprises were successfully decrypted Through comprehensive evaluation, price negotiation, joint negotiation and negotiation, 2160 products of 751 enterprises are recommended to win the bid 2111 of 753 enterprises were determined to win the bid, and 38 of 28 enterprises were transferred to Gansu pharmaceutical sunshine procurement platform In addition, a small number of drugs with a large increase in price and under price investigation will be announced after the completion of price investigation The original notice is as follows: each bidding enterprise: According to the notice on announcement (gyzf [2017] No.5) and the notice on bidding for centralized procurement of drugs by medical institutions in 2017 (gyzyz [2017] No.10) issued by the office of the leading group for centralized procurement of drugs and medical consumables in Gansu Province, under the coordination of the office of the leading group for centralized procurement of drugs and medical consumables Announcement release, data maintenance, qualification review, drug price information publicity, quotation decryption, comprehensive review, publicity of proposed bid winning results, handling of complaints and queries, expert review and other links, 2017-2018 Gansu public medical institutions drug centralized procurement work completed due process Now, the results of this round of centralized drug procurement bidding are published, and relevant matters are notified as follows: 1 The results of this round of public bidding, a total of 4205 product specifications of 977 enterprises participated in the bidding application, 3639 product specifications of 945 enterprises met the bidding requirements and entered the bidding process, 3383 product specifications of 905 enterprises were successfully quoted, and 3381 product specifications of 903 enterprises were successfully declassified Through comprehensive evaluation, price negotiation, joint negotiation and negotiation, 2160 products of 751 enterprises are recommended to win the bid 2111 of 753 enterprises were determined to win the bid, and 38 of 28 enterprises were transferred to Gansu pharmaceutical sunshine procurement platform In addition, a small number of drugs with a large increase in price and under price investigation will be announced after the completion of price investigation Please follow the website notice and announcement This result is the final result and will not be questioned by the appeal 2、 Notice on the handling of complaints and doubts (I) during the publicity period of the proposed bid winning results, 333 copies of complaints and doubts (including paper-based supplementary materials, involving 291 drugs, including 170 price related materials, 76 unsuccessful bid applications and 45 other materials) were received For all kinds of complaint and query materials submitted by the enterprise, the provincial drug purchasing agency held five meetings to discuss and discuss the handling opinions on the basis of group preliminary verification, cross review, sorting out and multi-dimensional retrieval of relevant review materials, multi-dimensional price analysis and comparison, communication with the enterprise, collective research and preparation of handling opinions See, and organize review experts to review on June 27, and complete the handling of all complaint and query materials and confirmation of bid winning results （2） The handling results of appeal and query shall be handled in accordance with the principles of full respect for the review opinions of review experts, full respect for market reality and fairness The specific complaint and query processing results have been replied in the complaint and query module of the bidding system, and each enterprise can log in to check 1 Principles for handling price complaints and queries: for those that exceed the price control limit but are at a lower level in the same bidding group or the lowest price level in the whole country of the enterprise, if there are multiple bidding results in the same bidding group and the drugs to be bid have been at a lower level in the whole country and the price is reasonable, and if further intervention will be unfair or cause new imbalance, no price consolidation will be carried out If the price difference is not significant or the reason for questioning is not tenable, it shall not be supported If the enterprise disagrees with the price arrangement, it shall be transferred to the pharmaceutical sunshine procurement platform of Gansu Province according to the proposed bid price 2 Handling principle of appeal and query of unsuccessful bid application at the meeting of leading group office: in accordance with the relevant policies of the state and provincial governments to encourage the priority use of drugs (including deemed pass) that pass the conformity evaluation of generic drugs, drugs that have obtained FDA / EU certification, drugs that are recommended by exclusive varieties, exclusive bidding groups, medical institutions or associations, and have special features for Gansu public welfare undertakings Enterprises with special contributions shall submit to experts for reconsideration on the premise of considering the implementation of policies and the guarantee of supply Those that are not recommended by the expert review but are encouraged by the policy to be used preferentially or clinically necessary shall be included in the sunshine hanging net 3、 After winning the bid, the new product specifications with different conversion coefficient or different packaging materials are all representative products The new product specifications with different conversion coefficient or packaging materials shall be compared according to the drug difference price comparison rules If the difference price is higher than the average price of the lowest nine provinces or the original winning price, it shall be supplemented according to the low principle Enterprises are requested to consciously declare according to the lowest price among the three The provincial drug purchasing agency will check the price of the new supplement regulations, adjust the price of those who fail to declare according to the requirements, and punish them according to the measures for the administration of good faith in centralized drug purchase All parties are welcome to supervise （1） Those who have maintained different conversion coefficients and packaging materials on the Internet at the time of bidding shall log in to the drug centralized procurement bidding platform of Gansu Province from July 4 to 12, 2019, and confirm the bidding price that has been calculated according to the differential price comparison rules If different conversion factors and materials are to be added, written supplementary materials shall be submitted as required In addition, for other series products with different calcium concentration and sugar concentration of peritoneal dialysis fluid winning the bid, the enterprise is requested to submit a written application for new price determination （2） If different conversion factors and packaging materials are not maintained on the Internet, written supplementary materials shall be submitted (the supplementary materials shall be stamped with the official seal of the enterprise) 1 The bid winning enterprise of required materials shall provide application, original specification, drug registration approval document and drug inspection report (provincial or municipal inspection or factory inspection after January 1, 2019) with different conversion coefficient (packaging quantity) 2 Time and place of submission: July 3-10, 2019 Location: Pharmaceutical purchasing office of Gansu public resources trading Bureau 3 Time for confirmation of price difference: to be notified after approval 4、 The notification of award shall be issued by the provincial public resources trading Bureau The original authorized bidder of the enterprise shall hold the ID card, and the new authorized person shall take the power of attorney, the original and copy of ID card to collect Issuing time of letter of acceptance: July 15 to July 31, 2019 Supervision telephone: v the implementation notice of the bid winning result shall be separately issued by the provincial drug and medical consumables centralized procurement leading group office Tel: 0931-2909385, 2909192, 2909381, 2909382 Appendix: 2017-2018 results of drug centralized procurement of public medical institutions in Gansu Province (http://125.74.7.48:8989/bdcp/sun/v-bid-normal-drug! Showbidresult Do) July 2, 2019